Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
0.1 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Pharma Mar, S.A. (PharmaMar)
EU Transparency Register
840804329063-93 First registered on 22 Nov 2017
Goals / Remit
PharmaMar is a company focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor activity. We are an integrated company that seeks innovative products to provide healthcare professionals with new tools to treat cancer. PharmaMar’s commitment to patients and to research has made it a world leader in the discovery of antitumor drugs of marine origin.
Main EU files targeted
European Medicines Agency activities
Industrial policy
Research policy
Public funding for researchAddress
Head Office
Av. de los Reyes, 1Colmenar Viejo
MADRID 28770
SPAINEU Office
Plaza del Descubridor Diego de Ordás3
Madrid 28003
SPAINWebsite
-
People
Total lobbyists declared
1
Employment time Lobbyists 10% 1 Lobbyists (Full time equivalent)
0.1
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Spanish Association for Biotechnology
www.asebio.comMember organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
Type Name Amount Grant Horizon Europe 156,916€ Intermediaries for closed year
Name Amount acento public affairs, s.l 50,000€ - 99,999€ Intermediaries for current year
None declaredClosed year Costs
100,000€ - 199,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
Horizon Europe
Drug Approval proceduresOther activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 24 Nov 2017 Location Brussels Subject Pharmaceutical policy Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists